A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy Participants

Clinical trial NCT05818514 · COMPLETED

Trial details

NCT number: NCT05818514
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-04-27
Primary completion: 2023-07-11
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.